-transparent.png){kind=logo}
It is important to localize the site of abnormal parathyroid glands in treatment of primary hyperparathyroidism. Selective venous sampling with parathyroid hormone assay is one of the methods for localization of adenoma or hyperplasia in primary hyperparathyroidism. Since Reitz first described it in 1969, it has been improved during the last two decades and there is a high sensitivity (70-80%). Especially in those cases, localization is unknown in imaging methods, the first operation fails or the patients has previously been explored in the neck, venous sampling becomes a very useful method. How to perform, indication, performance, strengths and weakness of selective venous sampling is described here.
K Tada, and
M Isaka, and
Y Okuda
August 2006,
Thyroid : official journal of the American Thyroid Association,
K Tada, and
M Isaka, and
Y Okuda
December 2006,
European journal of endocrinology,
K Tada, and
M Isaka, and
Y Okuda
February 1986,
The British journal of surgery,
K Tada, and
M Isaka, and
Y Okuda
January 2012,
Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion,
K Tada, and
M Isaka, and
Y Okuda
June 2015,
Journal of the American College of Surgeons,
K Tada, and
M Isaka, and
Y Okuda
July 1973,
The American journal of roentgenology, radium therapy, and nuclear medicine,
K Tada, and
M Isaka, and
Y Okuda
August 1976,
Radiologic clinics of North America,
K Tada, and
M Isaka, and
Y Okuda
December 2016,
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
K Tada, and
M Isaka, and
Y Okuda
November 2018,
The Laryngoscope,
